INTEGRATE

INTEGRATE CONSORTIUM BUILDS STAFF CAPACITY TO SUPPORT ONGOING CLINICAL TRIAL

AS INCLUSIONS FOR ITS CLINICAL TRIAL FOR A NEW LASSA FEVER TREATMENT PROGRESS, THE INTEGRATE CONSORTIUM CONTINUES TO STRENGTHEN STAFF […]

INTEGRATE CONSORTIUM BUILDS STAFF CAPACITY TO SUPPORT ONGOING CLINICAL TRIAL Read More »

Revolutionary INTEGRATE clinical trial seeking new Lassa fever treatment starts patient inclusions

News

In May 2025, the INTEGRATE clinical trial officially started first patient inclusions at one of West Africa’s leading Lassa Fever

Revolutionary INTEGRATE clinical trial seeking new Lassa fever treatment starts patient inclusions Read More »

The INTEGRATE treatment trial is funded by the European Union’s EDCTP3 programme under the sponsorship of ISTH, and with the French national medical research agency, ANRS-MIE as co-sponsor.

Scroll to Top